*/imgres?imgurl=https://european-biotechnology.com/wp-content/uploads/2024/04/guido-oelkers.jpg&imgrefurl=https://european-biotechnology.com/appointments/sobi-business-man/&h=473&w=420&tbnid=K5aDpLApAWUYfM&q=Guido+Oelkers&tbnh=129&tbnw=115&usg=AI4_-kQn-NUwxY3h93ImA1ZzTZyNDbV0UQ&vet=1&docid=mXJP7p2mnZzXpM&hl=sk&sa=X&ved=2ahUKEwjWyOL_0eyIAxXcGxAIHYGBOrYQ9QF6BAgAEAQ)
*/imgres?imgurl=https://www.egonzehnder.com/cdn/serve/article-images/1579727243-78dfd0fcf0fd170428edb2cb1d1e2773.jpg&imgrefurl=https://www.egonzehnder.com/annual-health-industry-leaders-dinner&h=731&w=756&tbnid=ZhrLMl8k1uEl7M&q=Guido+Oelkers&tbnh=137&tbnw=142&usg=AI4_-kSmhFT4BB0R8qWYLW1JVf8mIPEv9w&vet=1&docid=w4ORUS8IueLFOM&hl=sk&sa=X&ved=2ahUKEwjWyOL_0eyIAxXcGxAIHYGBOrYQ9QF6BAgAEAY)
*/imgres?imgurl=https://nordiclifescience.org/wp-content/uploads/2020/10/guido-oelkers-e1602667186369.jpg&imgrefurl=https://nordiclifescience.org/sobi-study-did-not-meet-primary-endpoints/&h=400&w=800&tbnid=1fuXoojtsFF75M&q=Guido+Oelkers&tbnh=72&tbnw=143&usg=AI4_-kT5dLd_DEK63r-rtTyqP-6CccyqQA&vet=1&docid=ECBXaI_FIPDpfM&hl=sk&sa=X&ved=2ahUKEwjWyOL_0eyIAxXcGxAIHYGBOrYQ9QF6BAgAEAg)
*/imgres?imgurl=https://image.nordjyske.dk/users/nordjyske/images/83566277.jpg?t%5Bstrip%5D%3Dtrue%26t%5Bresize%5D%5Bwidth%5D%3D3830%26t%5Bresize%5D%5Bheight%5D%3D2619%26accessToken%3D09c6b7254d39e8a57f6570b7a9c053e69b2bec9f6ee3d6b587e52c65a3815a98&imgrefurl=https://www.lifesciencesweden.se/article/view/1029655/sobis_vd_om_miljardforvarvet_ger_bade_tillvaxt_och_marginal&h=2619&w=3830&tbnid=3AfYDC-q8fPbUM&q=Guido+Oelkers&tbnh=103&tbnw=150&usg=AI4_-kTjH10naHrZ4dNBbtSfWbGJaENMmQ&vet=1&docid=QpYtI1dMEKcpXM&hl=sk&sa=X&ved=2ahUKEwjWyOL_0eyIAxXcGxAIHYGBOrYQ9QF6BAgAEAo)
*/imgres?imgurl=https://nordiclifescience.org/wp-content/public_html/2021/09/guido_oelkers-e1630919895713.png&imgrefurl=https://nordiclifescience.org/sobi-to-cease-refacto-manufacturing/&h=399&w=760&tbnid=2eamj8a6eYnBWM&q=Guido+Oelkers&tbnh=75&tbnw=142&usg=AI4_-kSPK4jH1MrDOWS7ESXBHFGQ6lQfGA&vet=1&docid=ZLjFvK49FIIauM&hl=sk&sa=X&ved=2ahUKEwjWyOL_0eyIAxXcGxAIHYGBOrYQ9QF6BAgAEAw)
*/imgres?imgurl=http://scrip.citeline.com/-/media/editorial/headshots/corporate/o/oelkers_guido_1200.jpg?rev%3D21eb1a829adc46918983528dec8e5256&imgrefurl=http://scrip.citeline.com/SC099746/New-CEO-Revamps-Top-Team-Specialty-Care-Business-At-Sobi&h=675&w=1200&tbnid=Nu6zJy3heYPQqM&q=Guido+Oelkers&tbnh=84&tbnw=150&usg=AI4_-kSrLTQE4Mtiq3oeGKrEk_wEV1bwsQ&vet=1&docid=RQGFQoBUdR80CM&hl=sk&sa=X&ved=2ahUKEwjWyOL_0eyIAxXcGxAIHYGBOrYQ9QF6BAgAEA4)
4. 5. 2024 · Says Oelkers has extensive experience from pharmaceutical and health care companies including a role as President and CEO of the Swedish ...
Guido Oelkers. Chief Executive Officer · 530,276. ; Henrik Stenqvist. Chief Financial Officer · 79,069. ; Lydia Abad-Franch. Chief Medical Officer, Head of R&D.
Guido Oelkers is a businessperson who has been at the helm of 8 different companies. Dr. Oelkers is President & Chief Executive Officer for Swedish Orphan ...
Guido Oelkers, Ph.D., is the Chief Executive Officer of Swedish Orphan Biovitrum since 2017. Prior to that, he worked for BSN medical.
Guido Oelkers is Chief Executive Officer at Swedish Orphan Biovitrum AB. See Guido Oelkers's compensation, career history, education, & memberships.
Download image 5.33 MB · Contacts · Careers · Healthcare professionals · Liberate Life. Follow us. Linkedin · Cookie policy · Privacy notice · Website terms ...
1. 8. 2024 · Swedish Orphan Biovitrum CEO & President Guido Oelkers Sells 38% Of Holding · The Last 12 Months Of Insider Transactions At Swedish Orphan ...
How to be a Successful CEO in a Private Equity Owned Company
www.egonzehnder.com › annual-health-i...
The 2019 discussion was held in Zurich with Guido Oelkers, CEO of SOBI, as the guest speaker. Oelkers is a well-known leader in the health industry with ...
News stories and articles referencing Guido Oelkers on European Pharmaceutical Review.